by Vandana Singh | Oct 16, 2026 | General
The U.S. Food and Drug Administration on Friday approved Roche Holdings AG (OTC:RHHBY) Enspryng (satralizumab) for thyroid eye disease. The regulatory action provides patients with the sole at-home subcutaneous treatment option currently available for this condition....
by Avi Kapoor | Oct 16, 2026 | General
U.S. stocks were mixed, with the Dow Jones index gaining around 250 points on Friday. Shares of Ladder Capital Corp (NYSE:LADR) rose sharply after the company announced upbeat third-quarter results. Ladder Capital reported quarterly earnings of 35 cents per share...
by Vandana Singh | Oct 16, 2026 | General
Fractyl Health Inc. (NASDAQ:GUTS) stock plunged nearly 50% in Friday’s trading despite the company reporting positive six-month clinical trial results for its Revita weight-loss treatment. The selloff comes as Fractyl faces an investor class action lawsuit over...
by Benzinga Insights | Oct 16, 2026 | General
Williams Companies (NYSE:WMB) has outperformed the market over the past 5 years by 7.72% on an annualized basis producing an average annual return of 19.1%. Currently, Williams Companies has a market capitalization of $89.03 billion. Buying $1000 In WMB: If an...
by Daragh Thomas | Oct 16, 2026 | General
The AI boom powering Nvidia Corp. (NASDAQ:NVDA) has entered its “manic phase,” Pulitzer Prize-winning historian Liaquat Ahamed warned Friday, comparing it to the railroad frenzy that ended in the Panic of 1873. Speaking on the Prof G Markets podcast, Ahamed said...
Recent Comments